BCTX Financial Statements

Balance sheet, income statement, cash flow, and dividends for Briacell Therapeutics Corp (BCTX).


$13.76M Market Cap.

As of 10/29/2024 5:00 PM ET (MRY) • Disclaimer

BCTX Market Cap. (MRY)


BCTX Shares Outstanding (MRY)


BCTX Assets (MRY)


Total Assets

$5.87M

Total Liabilities

$8.56M

Total Investments

$418.49K

BCTX Income (MRY)


Revenue

$0

Net Income

-$4.93M

Operating Expense

$33.33M

BCTX Cash Flow (MRY)


CF Operations

-$24.13M

CF Investing

-$681.80K

CF Financing

$4.42M

BCTX Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

-

-

0%

-

BCTX Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$5,872,261 (-78.38%)

$27,163,577 (-36.20%)

$42,577,041 (-26.65%)

$58,043,762 (14331.75%)

Assets Current

$3,653,854 (-86.44%)

$26,948,507 (-36.36%)

$42,346,700 (-26.73%)

$57,798,150 (28608.59%)

Assets Non-Current

$2,218,407 (931.48%)

$215,070 (-6.63%)

$230,341 (-6.22%)

$245,612 (22.28%)

Goodwill & Intangible Assets

$199,796 (-7.10%)

$215,068 (-6.63%)

$230,339 (-6.22%)

$245,610 (22.27%)

Shareholders Equity

-$2,382,410 (36.93%)

-$3,777,181 (-136.57%)

$10,328,932 (-62.67%)

$27,671,721 (1098.97%)

Property Plant & Equipment Net

$388,175 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Cash & Equivalents

$862,089 (-95.94%)

$21,251,092 (-48.22%)

$41,041,652 (-28.33%)

$57,268,685 (349910.30%)

Accumulated Other Comprehensive Income

-$138,684 (0.00%)

-$138,684 (0.00%)

-$138,684 (0.00%)

-$138,684 (-29.87%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$418,490 (20924400.00%)

$2 (0.00%)

$2 (0.00%)

$2 (0.00%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$418,490 (20924400.00%)

$2 (0.00%)

$2 (0.00%)

$2 (0.00%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$18,873 (-21.70%)

$24,103 (91.69%)

$12,574 (-27.47%)

Trade & Non-Trade Payables

$7,170,781 (538.12%)

$1,123,739 (142.56%)

$463,280 (116.37%)

$214,116 (-92.51%)

Accumulated Retained Earnings (Deficit)

-$85,443,697 (-5.94%)

-$80,652,231 (-33.64%)

-$60,349,837 (-107.09%)

-$29,141,897 (-108.30%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$0 (0%)

$0 (0%)

$0 (0%)

$25,986 (-91.68%)

Debt Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Debt Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$25,986 (-78.36%)

Total Liabilities

$8,557,193 (-72.34%)

$30,940,758 (-4.05%)

$32,248,109 (6.18%)

$30,372,041 (857.44%)

Liabilities Current

$7,461,157 (314.17%)

$1,801,457 (91.42%)

$941,087 (69.02%)

$556,795 (-81.76%)

Liabilities Non-Current

$1,096,036 (-96.24%)

$29,139,301 (-6.92%)

$31,307,022 (5.00%)

$29,815,246 (24730.73%)

BCTX Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$6,152,269 (-22.47%)

$7,935,626 (9.19%)

$7,267,452 (46.67%)

$4,955,136 (325.63%)

Research & Development Expense

$27,177,807 (77.21%)

$15,336,638 (91.19%)

$8,021,489 (296.93%)

$2,020,899 (8.19%)

Operating Expenses

$33,330,076 (43.22%)

$23,272,264 (52.22%)

$15,288,941 (119.16%)

$6,976,035 (129.98%)

Interest Expense

$0 (0%)

-$2,969,870 (-125.71%)

$11,549,962 (68.86%)

$6,840,165 (30032.89%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$4,791,466 (76.40%)

-$20,302,394 (24.35%)

-$26,838,903 (-94.26%)

-$13,816,200 (-345.84%)

Net Income to Non-Controlling Interests

$140,082 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$4,931,548 (75.71%)

-$20,302,394 (24.35%)

-$26,838,903 (-94.26%)

-$13,816,200 (-345.84%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$4,931,548 (75.71%)

-$20,302,394 (24.35%)

-$26,838,903 (-94.26%)

-$13,816,200 (-345.84%)

Weighted Average Shares

$16,454,932 (5.35%)

$15,619,676 (0.81%)

$15,494,091 (242.82%)

$4,519,579 (533.09%)

Weighted Average Shares Diluted

$16,454,932 (5.35%)

$15,619,676 (0.81%)

$15,494,091 (242.82%)

$4,519,579 (533.09%)

Earning Before Interest & Taxes (EBIT)

-$4,931,548 (78.81%)

-$23,272,264 (-52.22%)

-$15,288,941 (-119.16%)

-$6,976,035 (-126.77%)

Gross Profit

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Operating Income

-$33,330,076 (-43.22%)

-$23,272,264 (-52.22%)

-$15,288,941 (-119.16%)

-$6,976,035 (-129.98%)

BCTX Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$681,801 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow from Financing

$4,418,926 (11.75%)

$3,954,300 (205.65%)

-$3,742,657 (-105.76%)

$64,997,624 (7089.75%)

Net Cash Flow from Operations

-$24,126,128 (-1.61%)

-$23,744,860 (-90.20%)

-$12,484,376 (-61.08%)

-$7,750,188 (-695.10%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$20,389,003 (-3.02%)

-$19,790,560 (-21.96%)

-$16,227,033 (-128.35%)

$57,247,436 (81058.59%)

Net Cash Flow - Business Acquisitions and Disposals

-$225,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Capital Expenditure

-$456,801 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

$0 (0%)

-$330,398 (-2009.93%)

Issuance (Purchase) of Equity Shares

$4,418,926 (11.75%)

$3,954,300 (207.98%)

-$3,661,964 (-105.61%)

$65,328,022 (7267.27%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$1,804,078 (-17.76%)

$2,193,790 (-28.65%)

$3,074,584 (56.21%)

$1,968,226 (151535.29%)

Depreciation Amortization & Accretion

$83,897 (449.39%)

$15,271 (-0.01%)

$15,272 (0.10%)

$15,256 (29.88%)

BCTX Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

-

-

-

-

Profit Margin

-

-

-

-

EBITDA Margin

-

-

-

-

Return on Average Equity (ROAE)

141.90% (-98.92%)

13188.10% (15452.85%)

-85.90% (47.62%)

-164.00% (-187.33%)

Return on Average Assets (ROAA)

-46.00% (26.63%)

-62.70% (7.11%)

-67.50% (3.71%)

-70.10% (91.58%)

Return on Sales (ROS)

-

-

-

-

Return on Invested Capital (ROIC)

-1609.20% (41.03%)

-2728.70% (46.53%)

-5103.00% (-1208.87%)

460.20% (137.09%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0%

Price to Earnings Ratio (P/E)

-2.6 (49.57%)

-5.15 (-36.97%)

-3.76 (-126.33%)

-1.66

Price to Sales Ratio (P/S)

-

-

-

-

Price to Book Ratio (P/B)

-5.78 (79.60%)

-28.31 (-389.87%)

9.77 (605.56%)

1.38

Debt to Equity Ratio (D/E)

-3.59 (56.15%)

-8.19 (-362.36%)

3.12 (184.34%)

1.1 (195.90%)

Earnings Per Share (EPS)

-0.29 (77.69%)

-1.3 (24.86%)

-1.73 (43.46%)

-3.06 (29.54%)

Sales Per Share (SPS)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

-1.49 (1.71%)

-1.52 (-88.59%)

-0.81 (53.00%)

-1.72 (-25.64%)

Book Value Per Share (BVPS)

-0.14 (40.08%)

-0.24 (-136.28%)

0.67 (-89.11%)

6.12 (257.81%)

Tangible Assets Book Value Per Share (TABVPS)

0.34 (-80.00%)

1.73 (-36.88%)

2.73 (-78.63%)

12.79 (4434.75%)

Enterprise Value Over EBIT (EV/EBIT)

-3 (0.00%)

-3 (25.00%)

-4 (-33.33%)

-3

Enterprise Value Over EBITDA (EV/EBITDA)

-2.65 (21.88%)

-3.39 (22.32%)

-4.36 (-57.14%)

-2.77

Asset Turnover

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Current Ratio

0.49 (-96.72%)

14.96 (-66.76%)

45 (-56.65%)

103.81 (157180.30%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$24,582,929 (-3.53%)

-$23,744,860 (-90.20%)

-$12,484,376 (-61.08%)

-$7,750,188 (-695.10%)

Enterprise Value (EV)

$12,823,513 (-83.72%)

$78,747,648 (18.27%)

$66,581,201 (244.86%)

$19,306,523

Earnings Before Tax (EBT)

-$4,931,548 (75.71%)

-$20,302,394 (24.35%)

-$26,838,903 (-94.26%)

-$13,816,200 (-345.84%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$4,847,651 (79.16%)

-$23,256,993 (-52.27%)

-$15,273,669 (-119.42%)

-$6,960,779 (-127.15%)

Invested Capital

-$2,650,781 (-168.04%)

$3,895,960 (970.43%)

$363,963 (27220.94%)

-$1,342 (99.95%)

Working Capital

-$3,807,303 (-115.14%)

$25,147,050 (-39.27%)

$41,405,613 (-27.66%)

$57,241,355 (2107.90%)

Tangible Asset Value

$5,672,465 (-78.95%)

$26,948,509 (-36.36%)

$42,346,702 (-26.73%)

$57,798,152 (28608.45%)

Market Capitalization

$13,759,207 (-87.13%)

$106,917,747 (6.00%)

$100,867,117 (163.46%)

$38,286,268

Average Equity

-$3,476,052 (-2158.00%)

-$153,944 (-100.49%)

$31,247,322 (270.83%)

$8,426,307 (610.64%)

Average Assets

$10,731,452 (-66.85%)

$32,374,258 (-18.54%)

$39,744,953 (101.61%)

$19,714,216 (5195.39%)

Invested Capital Average

$306,454 (-64.07%)

$852,859 (184.66%)

$299,608 (119.77%)

-$1,515,827 (4.37%)

Shares

18,284,661 (14.41%)

15,981,726 (2.99%)

15,518,018 (105.90%)

7,536,667 (13.26%)